Bristol Myers Squibb (BMY)
(Delayed Data from NYSE)
$44.03 USD
-0.08 (-0.18%)
Updated May 17, 2024 03:59 PM ET
After-Market: $44.04 +0.01 (0.02%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth D Momentum B VGM
Brokerage Reports
Bristol Myers Squibb Company [BMY]
Reports for Purchase
Showing records 141 - 160 ( 438 total )
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for BMY.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for BMY.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for BMY.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended October 23
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for BMY.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for BMY.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for BMY.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended September 11
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D